California Rare Disease Access Coalition

Support for Champions for Vaccine Education, Equity and Progress has been provided by Johnson & Johnson, Moderna, Novartis, Novavax, and Pfizer, Inc.

Contact Us

Content on this site is being updated to reflect the FDA’s August 27 approval of the 2026–2027 COVID-19 vaccine formula. Please check back soon.